ID   201B2
AC   CVCL_A063
SY   201-B2; KUIFMSi004-D; vWT-201B2
DR   GEO; GSM1040248
DR   GEO; GSM1040318
DR   hPSCreg; KUIFMSi004-D
DR   ISCR; 35
DR   SKIP; SKIP000536
DR   SKIP; SKIP001161
DR   SKIP; SKIP002370
DR   Wikidata; Q54583058
RX   PubMed=18035408;
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Omics: DNA methylation analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=18035408
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,14
ST   D16S539: 11,13
ST   D18S51: 14
ST   D21S11: 28
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 8,10
ST   FGA: 20,22
ST   Penta D: 8,10
ST   Penta E: 7,19
ST   TH01: 5
ST   TPOX: 8,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 16
RX   PubMed=18035408; DOI=10.1016/j.cell.2007.11.019;
RA   Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K.,
RA   Yamanaka S.;
RT   "Induction of pluripotent stem cells from adult human fibroblasts by
RT   defined factors.";
RL   Cell 131:861-872(2007).
RX   PubMed=24259714; DOI=10.1073/pnas.1319061110;
RA   Koyanagi-Aoi M., Ohnuki M., Takahashi K., Okita K., Noma H.,
RA   Sawamura Y., Teramoto I., Narita M., Sato Y., Ichisaka T., Amano N.,
RA   Watanabe A., Morizane A., Yamada Y., Sato T., Takahashi J.,
RA   Yamanaka S.;
RT   "Differentiation-defective phenotypes revealed by large-scale analyses
RT   of human pluripotent stem cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:20569-20574(2013).